N/A N=184 Randomized Other

A Comparison of the First Attempt Success Rate of Cannulation Between the Accuvein Apparatus and Standard Technique

Procedural Complication

Bottom Line

View on ClinicalTrials.gov: NCT03462745 ↗

Enrolled (actual)

184

Serious AEs

0.0%

Results posted

Feb 2019

Primary outcome: Primary: First Attempt Success Rates With the AccuVein 300 Device Versus Standard Method — 92; 92 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: AccuVein AV 300 (Device)
Age: Pediatric, Adult
Sex: All
Sponsor: American University of Beirut Medical Center
Primary completion: Feb 2014

Outcome Measures

Outcome	Result	p-value
PRIMARY First Attempt Success Rates With the AccuVein 300 Device Versus Standard Method	92; 92	—

Summary

Background: The AccuVein AV300 device helps in venepuncture and intravenous (IV) cannulation. It uses infrared light that can be absorbed by the blood hemoglobin so that veins location is clearly viewed on the skin's surface. Objectives: To assess the effectiveness of the AV300 device over the standard technique in increasing the ﬁrst-time success rate (SR) for pediatric patients who needed IV cannulation. Methods: This was a prospective cross study of patients aged 0-18 years scheduled for surgery or examination under anesthesia but without having an existing IV access and after providing consent form. Patients were randomized into two groups; cannulation with AV300 or standard insertion performed by experienced pediatric anesthesiologists and residents under training.

Eligibility Criteria

Inclusion Criteria

Patients less than 18 years of age, American Society of Anesthesiologist Physical Status (ASA) status I, II or III, undergoing elective surgery or examination under anesthesia, which did not have existing intravenous access.

Exclusion Criteria

Existing intravenous access, malformations or infections at the potential site of insertion, need for emergency surgery, and inability or unwillingness of parent or legal guardian to give written informed consent.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03462745). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.